Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-week randomized double-blind placebo-controlled study of AZD9668 in COPD
2008-000724-12Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AZD9668 with Placebo (2 arms). Primary endpoint: Tolerability of AZD9668 over 14 days. Started Jun 2008; status: completed.
02
Drugs
alvelestat
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-000724-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000724-12.